In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

Major pharmacy-benefit managers generated $7.3 billion in markups on specialty drugs from pharmacies they are affiliated with, the FTC said in a new report.

which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Erika Rasure is globally-recognized as a ...

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being ...

A new lawsuit challenges Minnesota’s law for regulating pharmacy benefit managers, a group of companies that structure drug benefits within health insurance plans that critics have accused of ...

The legislation comes amid growing scrutiny of PBM practices. In September 2023, the Federal Trade Commission (FTC) sued the nation's three largest PBMs, alleging their rebate practices ...

Tractor Supply's nearly $15 billion annual revenue and its current value on the stock market rank the business among the largest public companies headquartered in the Nashville area. The company ...

Lawmakers ended 2024 on the cusp of passing a significant health package, including changes to the pharmacy benefit manager (PBM) industry payments to community health centers, a rollback of ...

Douglas Hoey, said in a statement, “PBM reform would rein in the big health insurance lobby, save taxpayers $5 billion, and throw a lifeline to the thousands of small, family-owned pharmacies ...